Status:
COMPLETED
Plasma Glucagon-like Peptide-1 Levels and In-hospital Complications in ST-segment Elevation Myocardial Infarction
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
STEMI - ST Elevation Myocardial Infarction
Glucagon-like Peptide-1
Eligibility:
All Genders
Brief Summary
Glucagon-like peptide-1 (GLP-1), produced mainly in enteroendocrine cells, participates in energy homeostasis and glucose metabolism by regulating islet hormone secretion, gastrointestinal motility, a...
Eligibility Criteria
Inclusion
- a diagnosis of STEMI and needed PCI
Exclusion
- patients with cancer patients who used DPP4 inhibitor patients who used GLP1 analogue
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
564 Patients enrolled
Trial Details
Trial ID
NCT03314844
Start Date
February 1 2013
End Date
February 1 2015
Last Update
October 20 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.